| |
FDA loosens restrictions on nicotine replacement products Monday, Apr 01, 2013 12:25 PM PDT | Top |
North Dakota abortion clinic vows fight against tough new state laws Monday, Apr 01, 2013 11:19 AM PDT | Top |
Texas governor reiterates opposition to Medicaid expansion Monday, Apr 01, 2013 11:13 AM PDT | Top |
Federal government slashes New York's Medicaid payments Monday, Apr 01, 2013 11:08 AM PDT | Top |
Looking for a fitness buddy? Get a dog Monday, Apr 01, 2013 10:11 AM PDT By Dorene Internicola NEW YORK (Reuters) - Zeus the pit bull helps his owner slog through interval training and military crawls, Goldie and her master enjoy Tai Chi together and Izzie the three-legged shih tzu can't hike up the mountain but she acts as a hand weight for her owner's bicep curl. Experts say a dog may be man's best fitness friend, and dog-and-master workouts don't have to be limited to a run on the beach or a Frisbee toss. "Unlike humans, their motivation never peters out. Dogs don't drop off one by one, like other fitness buddies," said Dr. ... Full Story | Top |
S. Africa's Mandela visited by family after weekend improvement Monday, Apr 01, 2013 09:35 AM PDT | Top |
South Africa's Mandela visited by family after weekend improvement Monday, Apr 01, 2013 09:33 AM PDT | Top |
Novartis loses landmark India cancer drug patent case Monday, Apr 01, 2013 07:43 AM PDT | Top |
No sign of human transmission in new bird flu appearance: WHO Monday, Apr 01, 2013 06:45 AM PDT BEIJING (Reuters) - The World Health Organization says no evidence has emerged to show that a type of bird flu which has killed two Chinese men can be transmitted between people. Two men in Shanghai, aged 87 and 27, fell sick in late February. A woman in Anhui province also contracted the virus in early March and is in critical condition. "At this point, these three are isolated cases with no evidence of human-to-human transmission", the WHO representative in China, Dr. Michael O'Leary, told reporters on Monday. ... Full Story | Top |
India hails "historic" Supreme Court drug patent ruling against Novartis Monday, Apr 01, 2013 04:00 AM PDT NEW DELHI (Reuters) - The Indian government hailed as "historic" a Supreme Court ruling on Monday against a plea by Swiss drugmaker Novartis AG to protect the patent on its drug Glivec. Commerce and Industry Minister Anand Sharma said the ruling -- seen as a victory by health rights campaigners -- reaffirmed provisions in Indian law that mandate the need for substantial innovation before new patents are issued on medicines. (Reporting By Matthias Williams; Writing by Frank Jack Daniel, editing by Ross Colvin) Full Story | Top |
Novartis India will continue to file for patents: executive Monday, Apr 01, 2013 02:30 AM PDT MUMBAI (Reuters) - Novartis India Ltd, a unit of Swiss drugmaker Novartis AG, will continue to file for patents in India, its vice chairman said on Monday, after the country's top court rejected its plea for patent protection of its drug Glivec. Novartis India will also continue to invest there, but with caution, Ranjit Shahani, who is also the managing director of the company, told reporters after the Supreme Court judgment. ... Full Story | Top |
Octogenarian Japanese climber aims for Everest record Sunday, Mar 31, 2013 11:53 PM PDT | Top |
GERD label makes parents more likely to want medicine Sunday, Mar 31, 2013 09:14 PM PDT By Genevra Pittman NEW YORK (Reuters Health) - Telling the parents of babies who spit up and cry frequently that their child has gastroesophageal reflux disease, or GERD, makes them more likely to want medicine - even if they're also told it isn't likely to help much, a new study suggests. Most babies who spit up don't have an acid reflux problem, researchers said, just a not-quite-developed upper stomach valve. Still, an increasing number of those kids are being labeled as having GERD - even though a definitive diagnosis normally requires an invasive test. ... Full Story | Top |
Insight: China's losing battle against state-backed polluters Sunday, Mar 31, 2013 06:58 PM PDT | Top |
|
No comments:
Post a Comment